Clinical Trials Directory

Trials / Conditions / Apathy

Apathy

58 registered clinical trials studyying Apathy19 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingSENS'REM - SENSoriality and Multi-Sensory Emotional Reminiscences: a Pilot Study
NCT07468305
Centre Hospitalier Universitaire de NiceN/A
RecruitingSafety and Tolerability of IRL757 in Participants With Parkinson's Disease and Apathy
NCT07461220
Integrative Research Laboratories ABPhase 1 / Phase 2
Not Yet RecruitingRobotic Technologies for APATHy in Dementia: a Randomised Controlled Trial (RAPHAel)
NCT07404410
Giovanna ZamboniN/A
RecruitingCombined Brain Stimulation and Methylphenidate Treatment for Apathy in Dementia
NCT07279740
Sunnybrook Health Sciences CentrePhase 2
RecruitingEffects of Personalized Digital Reminiscence Therapy on Patients With Neurocognitive Disorders
NCT07237009
KompanionCare SAS
RecruitingTargeting Network Dysfunction in Apathy of Late-life Depression Using Digital Therapeutics
NCT05877885
AdventHealthN/A
Not Yet RecruitingVC/VS for Apathy in PD
NCT06991335
Nora VanegasN/A
RecruitingA Virtual Life Story Club Intervention to Improve Loneliness and Apathy in Community-Dwelling Older Adults
NCT06919094
Montefiore Medical CenterN/A
RecruitingAccelerated rTMS vs. Sham for Stroke Apathy
NCT07113067
Medical University of South CarolinaPhase 1 / Phase 2
RecruitingRespiratory-gated Transcutaneous Auricular Vagus Nerve Stimulation for Improving Apathy in Parkinson's Disease
NCT07118956
Anhui Medical UniversityN/A
Not Yet RecruitingEffort and Antidepressant Study Test
NCT06696482
University of OxfordPhase 1 / Phase 2
Enrolling By InvitationA Randomized Double-Blind Active-Controlled Crossover Trial of Respiratory-Gated Versus Non-Gated Transcutaneo
NCT06642454
Anhui Medical UniversityN/A
CompletedPhase I Trial Evaluating the Pharmacokinetics of Single Ascending Oral Doses of IRL757 in Healthy Elderly Volu
NCT06699628
Integrative Research Laboratories ABPhase 1
RecruitingApathy-related Neurobehavioral Markers of Cognitive Decline in Old-age Bipolar Disorders: Proof-of-concept
NCT06914284
Hospital Center Guillaume Régnier
RecruitingLumateperone for the Improvement of Apathy in Patients With Psychotic Symptoms.
NCT06482554
Louisiana State University Health Sciences Center ShreveportPhase 3
Not Yet RecruitingStratifying Psychoses for Personalized REpetitive TMS in Persistent NEgative Symptoms Alleviation
NCT06184165
University Hospital, Strasbourg, FranceN/A
Not Yet RecruitingMethylphenidate for Apathy in Veterans With Parkinson's Disease
NCT05669170
Ralph H. Johnson VA Medical CenterPhase 2
CompletedAccelerated rTMS for Post-Stroke Apathy
NCT05878457
Medical University of South CarolinaPhase 1
CompletedCognitive Stimulation Therapy
NCT05808530
Hasan Kalyoncu UniversityN/A
CompletedLifestyle Intervention for Improving Insulin Resistance and Concern for Health
NCT05649176
Pennington Biomedical Research CenterN/A
RecruitingEsketamine Nasal Spray in Real-World Settings in Treatment-Resistant Depression
NCT07146503
Riccardo Guglielmo
TerminatedEffect of Istradefylline Treatment on Behavioral Measures of Apathy in Parkinson's Disease.
NCT05182151
Medical University of South Carolina
Active Not RecruitingEffects of t-DCS and Cognitive Training on Apathy in Elderly With Minor Neurocognitive Impairment
NCT05232877
Centre Hospitalier Universitaire de NiceN/A
UnknownStudy of the Effectiveness of Mental Contrasting and Implementation Intention in the Management of Apathy in S
NCT04781179
University Hospital, MontpellierN/A
RecruitingTargeting Apathy With Music in Parkinson's Disease
NCT05505019
University of British ColumbiaN/A
RecruitingMultidimensional Apathy in Psychiatric Pathologies.
NCT04757220
University Hospital, Strasbourg, FranceN/A
UnknownNon-disabling Ischemic Cerebrovascular Event With Apathy
NCT04917237
Changhai Hospital
UnknownIn Vivo Involvement of the Cholinergic and Dopaminergic Systems in the Pathophysiology of Apathy.
NCT03998852
University Hospital, BordeauxPhase 3
CompletedThe Effects of Apathy on Different Forms of Fatigue
NCT04573712
Centre Hospitalier Universitaire de NiceN/A
UnknownMotive-specific Intervention for Negative Symptoms in Schizophrenia
NCT04793438
University of ZurichN/A
CompletedMove to Improve Physical Activity in Parkinson's Disease
NCT04051151
University of PennsylvaniaN/A
CompletedTranscranial Magnetic Stimulation for Apathy in Mild Cognitive Impairment
NCT03590327
VA Office of Research and DevelopmentN/A
UnknownDementia Associated Apathy.
NCT03293537
Zurich University of Applied SciencesN/A
CompletedAssessment of Apathy in a Real-life Situation, With a Video and Sensors-based System
NCT03272230
Institut National de la Santé Et de la Recherche Médicale, FranceN/A
CompletedMotivation and Methylphenidate
NCT03190681
Institut National de la Santé Et de la Recherche Médicale, FranceEARLY_Phase 1
CompletedEvolution of Hypodopaminergic Syndrome in Early Parkinson's Disease
NCT03141944
University Hospital, Grenoble
TerminatedTranscranial Direct Current Stimulation (tDCS) in Chronic Post-Stroke Apathy
NCT02915484
Stony Brook UniversityN/A
CompletedApathy in Tourette Syndrome and Changes in Quality of Life
NCT02765178
University of Florida
CompletedApathy in Dementia Methylphenidate Trial 2
NCT02346201
Johns Hopkins Bloomberg School of Public HealthPhase 3
CompletedQuantitative Evaluation of Apathy Close to Real Life Situation by Means of a Multimodal Sensor System Integrat
NCT02496312
Institut National de la Santé Et de la Recherche Médicale, FranceN/A
CompletedRepetitive Transcranial Magnetic Stimulation for Apathy in Alzheimer's Dementia
NCT02190084
Central Arkansas Veterans Healthcare SystemPhase 4
UnknownTranscranial Magnetic Stimulation for Apathy in Mild Cognitive Impairment:Pilot Study
NCT02190019
Central Arkansas Veterans Healthcare SystemPhase 4
UnknownEvaluation of the Efficacy of Rasagiline in Apathy in Drug-naïve Patients With Parkinson's Disease by a Multi-
NCT01765257
University Hospital, Clermont-FerrandPhase 4
UnknownRepetitive Transcranial Magnetic Stimulation for Apathy Treatment in Alzheimer's Disease
NCT01885806
Federal University of Minas GeraisPhase 2
CompletedRole of Mesocorticolimbic Pathway in Apathy of Patients With Parkinson's Disease. - Study Using Diffusion Tens
NCT01794195
University Hospital, Clermont-FerrandN/A
TerminatedExploring the Use of Transdermal Methylphenidate to Reduce Fall Risk in Patients With Dementia.
NCT01825577
St. Louis UniversityPhase 4
CompletedApathy in Schizophrenia
NCT01689181
Institut National de la Santé Et de la Recherche Médicale, France
UnknownNon Motors Aspects in De Novo Parkinson's Disease
NCT02786667
University Hospital, GrenoblePhase 3
CompletedApathy Cure Through Bupropion in Huntington's Disease
NCT01914965
Charite University, Berlin, GermanyPhase 2
CompletedEffects of Transcranial Direct Current Stimulation on the Apathy of Alzheimer's Disease
NCT01481558
University of Sao PauloPhase 2
CompletedApathy in Dementia Methylphenidate Trial (ADMET)
NCT01117181
Johns Hopkins Bloomberg School of Public HealthPhase 2
CompletedThe Role of Apathy in Glycemic Control
NCT00844090
US Department of Veterans AffairsN/A
CompletedStudy of Rivastigmine to Treat Parkinsonian Apathy Without Dementia
NCT00767091
University Hospital, LillePhase 3
WithdrawnImproving Function, Quality of Life, Glycemia in Diabetics With Dementia
NCT00792662
University of NebraskaPhase 4
CompletedRole of Apathy in the Effectiveness of Weight Loss Interventions
NCT00548652
VA Nebraska Western Iowa Health Care SystemN/A
CompletedMethylphenidate for Apathy in Alzheimer's Dementia: A Controlled Study
NCT00495820
VA Office of Research and DevelopmentPhase 4
CompletedTreatment of Apathy in Alzheimer's Disease With Modafinil
NCT01172145
Brown UniversityPhase 3
CompletedWellbutrin XL Effects on SSRIs Induced Changes
NCT00456820
Indiana University School of MedicinePhase 4